Search research articles
Contact Us
Filters
Showing results (101-110 of 119) with videos related to
Page
of 12
Sort By:
Bone Marrow Transplantation
|
July 26, 2020
<sup>90</sup>Y-labeled anti-CD45 antibody allogeneic hematopoietic cell transplantation for high-risk multiple myeloma
Sherilyn A Tuazon, Brenda M Sandmaier, Theodore A Gooley, et al.
Transplantation and Cellular Therapy
|
September 27, 2020
Yttrium-90 Anti-CD45 Immunotherapy Followed by Autologous Hematopoietic Cell Transplantation for Relapsed or Refractory Lymphoma
Sherilyn A Tuazon, Ryan D Cassaday, Theodore A Gooley, et al.
Haematologica
|
March 13, 2025
Real-world comparison of lisocabtagene maraleucel and axicabtagene ciloleucel in large B-cell lymphoma: an inverse probability of treatment weighting analysis with 3-year follow up
Andrew J Portuguese, Jennifer J Huang, Yein Jeon, et al.
American Journal of Hematology
|
May 7, 2019
Outcomes of patients with large B-cell lymphomas and progressive disease following CD19-specific CAR T-cell therapy
Victor A Chow, Ajay K Gopal, David G Maloney, et al.
Molecular Cancer Therapeutics
|
October 21, 2020
Therapy of Myeloid Leukemia using Novel Bispecific Fusion Proteins Targeting CD45 and <sup>90</sup>Y-DOTA
Johnnie J Orozco, Aimee L Kenoyer, Yukang Lin, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
September 9, 2015
Pretransplantation Minimal Residual Disease Predicts Survival in Patients with Mantle Cell Lymphoma Undergoing Autologous Stem Cell Transplantation in Complete Remission
Andrew J Cowan, Philip A Stevenson, Ryan D Cassaday, et al.
Transplantation and Cellular Therapy
|
August 2, 2025
Opportunities to Improve Antibiotic Stewardship, and Identification of Blood Biomarkers Associated with Bacteremia Following CAR-T Cell Therapy
Sai Kit Ng, Patrick W Flaherty, Melissa Ancheta, et al.
Blood
|
January 29, 2015
Astatine-211 conjugated to an anti-CD20 monoclonal antibody eradicates disseminated B-cell lymphoma in a mouse model
Damian J Green, Mazyar Shadman, Jon C Jones, et al.
Blood
|
April 8, 2025
A phase 1 trial of fully human BCMA CAR-T therapy for relapsed/refractory multiple myeloma with 5-year follow-up
Sherilyn A Tuazon, Andrew J Portuguese, Margot J Pont, et al.
Blood Advances
|
October 30, 2023
Timing of anti-PD-L1 antibody initiation affects efficacy/toxicity of CD19 CAR T-cell therapy for large B-cell lymphoma
Alexandre V Hirayama, Erik L Kimble, Jocelyn H Wright, et al.
Page
of 12
Search research articles
Search
Showing results (101-110 of 119) with videos related to
Sort By:
Page
of 12
Bone Marrow Transplantation
|
July 26, 2020
<sup>90</sup>Y-labeled anti-CD45 antibody allogeneic hematopoietic cell transplantation for high-risk multiple myeloma
Sherilyn A Tuazon, Brenda M Sandmaier, Theodore A Gooley, et al.
Transplantation and Cellular Therapy
|
September 27, 2020
Yttrium-90 Anti-CD45 Immunotherapy Followed by Autologous Hematopoietic Cell Transplantation for Relapsed or Refractory Lymphoma
Sherilyn A Tuazon, Ryan D Cassaday, Theodore A Gooley, et al.
Haematologica
|
March 13, 2025
Real-world comparison of lisocabtagene maraleucel and axicabtagene ciloleucel in large B-cell lymphoma: an inverse probability of treatment weighting analysis with 3-year follow up
Andrew J Portuguese, Jennifer J Huang, Yein Jeon, et al.
American Journal of Hematology
|
May 7, 2019
Outcomes of patients with large B-cell lymphomas and progressive disease following CD19-specific CAR T-cell therapy
Victor A Chow, Ajay K Gopal, David G Maloney, et al.
Molecular Cancer Therapeutics
|
October 21, 2020
Therapy of Myeloid Leukemia using Novel Bispecific Fusion Proteins Targeting CD45 and <sup>90</sup>Y-DOTA
Johnnie J Orozco, Aimee L Kenoyer, Yukang Lin, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation
|
September 9, 2015
Pretransplantation Minimal Residual Disease Predicts Survival in Patients with Mantle Cell Lymphoma Undergoing Autologous Stem Cell Transplantation in Complete Remission
Andrew J Cowan, Philip A Stevenson, Ryan D Cassaday, et al.
Transplantation and Cellular Therapy
|
August 2, 2025
Opportunities to Improve Antibiotic Stewardship, and Identification of Blood Biomarkers Associated with Bacteremia Following CAR-T Cell Therapy
Sai Kit Ng, Patrick W Flaherty, Melissa Ancheta, et al.
Blood
|
January 29, 2015
Astatine-211 conjugated to an anti-CD20 monoclonal antibody eradicates disseminated B-cell lymphoma in a mouse model
Damian J Green, Mazyar Shadman, Jon C Jones, et al.
Blood
|
April 8, 2025
A phase 1 trial of fully human BCMA CAR-T therapy for relapsed/refractory multiple myeloma with 5-year follow-up
Sherilyn A Tuazon, Andrew J Portuguese, Margot J Pont, et al.
Blood Advances
|
October 30, 2023
Timing of anti-PD-L1 antibody initiation affects efficacy/toxicity of CD19 CAR T-cell therapy for large B-cell lymphoma
Alexandre V Hirayama, Erik L Kimble, Jocelyn H Wright, et al.
Page
of 12